Article Details

FDA Declines Emergency Use Authorization for ZYESAMI® (aviptadil) for subgroup ... - PR Newswire

Retrieved on: 2022-07-01 13:47:57

Tags for this article:

Click the tags to see associated articles and topics

FDA Declines Emergency Use Authorization for ZYESAMI® (aviptadil) for subgroup ... - PR Newswire. View article details on HISWAI: https://www.prnewswire.com/news-releases/fda-declines-emergency-use-authorization-for-zyesami-aviptadil-for-subgroup-of-patients-with-critical-covid-19-at-immediate-risk-of-death-from-respiratory-failure-despite-treatment-with-approved-therapy-including-remdesivir-301579610.html

Excerpt

... with Critical COVID-19 at immediate risk of death from respiratory failure despite treatment with approved therapy, including remdesivir.

Article found on: www.prnewswire.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up